| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Yonglin Gao, Lukasz P Slomnicki, Ewa Kilanczyk, Michael D Forston, Maciej Pietrzak, Eric C Rouchka, Russell M Howard, Scott R Whittemore, Michal Hetma. Reduced Expression of Oligodendrocyte Linage-Enriched Transcripts During the Endoplasmic Reticulum Stress/Integrated Stress Response. ASN neuro. vol 16. issue 1. 2024-07-18. PMID:39024571. |
endoplasmic reticulum (er) stress in oligodendrocyte (ol) linage cells contributes to several cns pathologies including traumatic spinal cord injury (sci) and multiple sclerosis. |
2024-07-18 |
2024-07-21 |
rat |
| Sara Samadzadeh, Rafl Adnan, Paulina Berglova, Mahdi Barzegar, Birgit Debrabant, Stine Gundtoft Roikjaer, Michael Levy, Axel Petzold, Jacqueline Palace, Eoin P Flanagan, Sara Mariotto, Soeren T Skou, Anne Froelich, Itay Lotan, Silvia Messina, Ruth Geraldes, Susanna Asseyer, Hadas Stiebel-Kalish, Frederike Cosima Oertel, Vahid Shaygannejad, Mohammad Ali Sahraian, Ho Jin Kim, Jeffrey L Bennett, Chotima Böttcher, Hanna G Zimmermann, Brian G Weinshenker, Friedemann Paul, Nasrin Asgar. Protocol of a prospective multicenter study on comorbidity impact on multiple sclerosis and antibody-mediated diseases of the central nervous system (COMMIT). Frontiers in immunology. vol 15. 2024-07-18. PMID:39021565. |
comorbidities in patients with multiple sclerosis (ms) and antibody-mediated diseases of the central nervous system (cns) including neuromyelitis optica spectrum disorder (nmosd), and myelin oligodendrocyte glycoprotein (mog)-antibody-associated disease (mogad) are common and may influence the course of their neurological disease. |
2024-07-18 |
2024-07-20 |
human |
| Ashis Kumar Podder, Mohamed Alaa Mohamed, Richard A Seidman, Georgios Tseropoulos, Jessie J Polanco, Pedro Lei, Fraser J Sim, Stelios T Andreadi. Injectable shear-thinning hydrogels promote oligodendrocyte progenitor cell survival and remyelination in the central nervous system. Science advances. vol 10. issue 28. 2024-07-12. PMID:38996029. |
cell therapy for the treatment of demyelinating diseases such as multiple sclerosis is hampered by poor survival of donor oligodendrocyte cell preparations, resulting in limited therapeutic outcomes. |
2024-07-12 |
2024-07-15 |
human |
| Carson E Moseley, Akash Virupakshaiah, Thomas G Forsthuber, Lawrence Steinman, Emmanuelle Waubant, Scott S Zamvi. MOG CNS Autoimmunity and MOGAD. Neurology(R) neuroimmunology & neuroinflammation. vol 11. issue 5. 2024-07-12. PMID:38996203. |
at one time considered a possible form of neuromyelitis optica (nmo) spectrum disorder (nmosd), it is now accepted that myelin oligodendrocyte glycoprotein (mog) antibody (ab)-associated disorder (mogad) is a distinct entity from either nmo or multiple sclerosis (ms) and represents a broad spectrum of clinical phenotypes. |
2024-07-12 |
2024-07-15 |
Not clear |
| Cristina Agliardi, Franca Rosa Guerini, Milena Zanzottera, Elisabetta Bolognesi, Domenico Caputo, Marco Rovaris, Mario Cleric. Increased concentrations of P2X7R in oligodendrocyte derived extracellular vesicles of Multiple sclerosis patients. Neurobiology of disease. 2024-07-12. PMID:38996986. |
increased concentrations of p2x7r in oligodendrocyte derived extracellular vesicles of multiple sclerosis patients. |
2024-07-12 |
2024-07-15 |
human |
| Frederick Gyabaah, Cyrena Petersen, Emily Bateman, Abhizith Deoke. Acute-Onset Blindness in a Patient Diagnosed With Myelin Oligodendrocyte Glycoprotein Antibody Disease (MOG-AD): A Case Report. Cureus. vol 16. issue 6. 2024-07-08. PMID:38975430. |
myelin oligodendrocyte glycoprotein antibody disease (mog-ad) poses a diagnostic challenge, often masquerading as other neurological disorders such as multiple sclerosis and aquaporin-4-positive neuromyelitis optica spectrum disorder. |
2024-07-08 |
2024-07-11 |
Not clear |
| Hyunjin Ju, Yeon Hak Chung, Soonwook Kwon, Eun Bin Cho, Kyung-Ah Park, Ju-Hong Mi. Usefulness of the MFIS-K, FSS, and FACIT-F Fatigue Scales in Korean Patients With MS, NMOSD, and MOGAD. Journal of clinical neurology (Seoul, Korea). vol 20. issue 4. 2024-07-02. PMID:38951976. |
fatigue is common in demyelinating disorders of the central nervous system (cns), including multiple sclerosis (ms), neuromyelitis optica spectrum disorder (nmosd), and myelin oligodendrocyte glycoprotein antibody-associated disease (mogad). |
2024-07-02 |
2024-07-04 |
Not clear |
| Tais Estrela, Hadas Stiebel-Kalish, Leigh Rettenmaier, Amanda D Henderson, Elias Sotirchos, Yana Said, Gelareh Ahmadi, Deena A Tajfirouz, Eoin P Flanagan, Nanthaya Tisavipat, Ryan Gise, Bart K Chwalisz, John J Che. Optic Disc Cupping in Neuromyelitis Optica Spectrum Disorder, Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease, and Multiple Sclerosis and Its Relationship With Optical Coherence Tomography Parameters: A Multicenter Study. Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society. 2024-07-01. PMID:38946028. |
optic disc cupping in neuromyelitis optica spectrum disorder, myelin oligodendrocyte glycoprotein antibody-associated disease, and multiple sclerosis and its relationship with optical coherence tomography parameters: a multicenter study. |
2024-07-01 |
2024-07-03 |
Not clear |
| Tais Estrela, Hadas Stiebel-Kalish, Leigh Rettenmaier, Amanda D Henderson, Elias Sotirchos, Yana Said, Gelareh Ahmadi, Deena A Tajfirouz, Eoin P Flanagan, Nanthaya Tisavipat, Ryan Gise, Bart K Chwalisz, John J Che. Optic Disc Cupping in Neuromyelitis Optica Spectrum Disorder, Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease, and Multiple Sclerosis and Its Relationship With Optical Coherence Tomography Parameters: A Multicenter Study. Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society. 2024-07-01. PMID:38946028. |
the purpose of this study was to compare cupping in patients after on from multiple sclerosis (ms), neuromyelitis optica spectrum disorder (nmosd), or myelin oligodendrocyte glycoprotein antibody-associated disease (mogad) and to investigate the relationship between cupping and retinal nerve fiber layer (rnfl) and ganglion cell complex (gcc) thinning. |
2024-07-01 |
2024-07-03 |
Not clear |
| Rahimeh Emamnejad, Maurice Pagnin, Steven Petrato. The Iron Maiden: Oligodendroglial metabolic disfunction in multiple sclerosis and mitochondrial signalling. Neuroscience and biobehavioral reviews. 2024-07-01. PMID:38950685. |
multiple sclerosis (ms) is an autoimmune disease, governed by oligodendrocyte (ol) dystrophy and central nervous system (cns) demyelination manifesting variable neurological impairments. |
2024-07-01 |
2024-07-04 |
Not clear |
| Àlex Rovira, Angela Vidal-Jordana, Cristina Auger, Jaume Sastre-Garrig. Optic Nerve Imaging in Multiple Sclerosis and Related Disorders. Neuroimaging clinics of North America. vol 34. issue 3. 2024-06-28. PMID:38942524. |
optic neuritis is a common feature in multiple sclerosis and in 2 other autoimmune demyelinating disorders such as aquaporin-4 igg antibody-associated neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody-associated disease. |
2024-06-28 |
2024-07-01 |
Not clear |
| János György Pitter, László Nagy, Balázs Nagy, Rok Hre. Development Perspectives for Curative Technologies in Primary Demyelinating Disorders of the Central Nervous System with Neuromyelitis Optica Spectrum Disorder (NMOSD) and Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD) at the Forefront. Journal of personalized medicine. vol 14. issue 6. 2024-06-27. PMID:38929820. |
primary demyelinating disorders of the central nervous system (cns) include multiple sclerosis and the orphan conditions neuromyelitis optica spectrum disorder (nmosd) and myelin oligodendrocyte glycoprotein igg-associated disease (mogad). |
2024-06-27 |
2024-06-29 |
Not clear |
| Maria Rodi, Anne-Lise de Lastic, Ioannis Panagoulias, Ioanna Aggeletopoulou, Kostas Kelaidonis, John Matsoukas, Vasso Apostolopoulos, Athanasia Mouzak. Myelin Oligodendrocyte Glycoprotein (MOG)35-55 Mannan Conjugate Induces Human T-Cell Tolerance and Can Be Used as a Personalized Therapy for Multiple Sclerosis. International journal of molecular sciences. vol 25. issue 11. 2024-06-19. PMID:38892275. |
myelin oligodendrocyte glycoprotein (mog)35-55 mannan conjugate induces human t-cell tolerance and can be used as a personalized therapy for multiple sclerosis. |
2024-06-19 |
2024-06-21 |
mouse |
| Wenjing Luo, Xiaonan Zhong, Shishi Shen, Ling Fang, Yiying Huang, Yuge Wang, Wei Qi. A comparative study of hypothalamic involvement in patients with myelin oligodendrocyte glycoprotein antibody-associated disease, neuromyelitis optica spectrum disorder, and multiple sclerosis. European journal of neurology. 2024-06-12. PMID:38863307. |
a comparative study of hypothalamic involvement in patients with myelin oligodendrocyte glycoprotein antibody-associated disease, neuromyelitis optica spectrum disorder, and multiple sclerosis. |
2024-06-12 |
2024-06-14 |
Not clear |
| Wenjing Luo, Xiaonan Zhong, Shishi Shen, Ling Fang, Yiying Huang, Yuge Wang, Wei Qi. A comparative study of hypothalamic involvement in patients with myelin oligodendrocyte glycoprotein antibody-associated disease, neuromyelitis optica spectrum disorder, and multiple sclerosis. European journal of neurology. 2024-06-12. PMID:38863307. |
we aimed to characterize hypothalamic involvement in myelin oligodendrocyte glycoprotein antibody-associated disease (mogad) and compare it with neuromyelitis optica spectrum disorder (nmosd) and multiple sclerosis (ms). |
2024-06-12 |
2024-06-14 |
Not clear |
| Abudurousuli Adili, Aerken Dilihumaer, Huhu Zhu, Huifang Tan. Research progress on phosphodiesterase 4 inhibitors in central nervous system diseases. Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences. 2024-06-11. PMID:38860393. |
pde4 inhibitors can also promote the differentiation of oligodendrocyte progenitor cells and enhance myelination, which has potential in the treatment of multiple sclerosis. |
2024-06-11 |
2024-06-14 |
Not clear |
| Yuqing Wu, Hao Zhou, Xiaojiao Ci, Jie L. Low T3 syndrome is associated with the severity of myelin oligodendrocyte glycoprotein antibody-associated disease exacerbation. Frontiers in neuroscience. vol 18. 2024-06-05. PMID:38835837. |
myelin oligodendrocyte glycoprotein antibody-associated disease (mogad) is a rare autoimmune inflammatory disease of the central nervous system, (cns) different from multiple sclerosis (ms) and neuromyelitis optica spectrum disorder (nmosd). |
2024-06-05 |
2024-06-07 |
Not clear |
| Larissa Jank, Riley B Catenacci, Veronica Minney, Danny Galleguillos, Peter A Calabres. Pharmacological modulation of inflammatory oligodendrocyte progenitor cells using three multiple sclerosis disease modifying therapies in vitro. Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics. 2024-05-26. PMID:38797642. |
pharmacological modulation of inflammatory oligodendrocyte progenitor cells using three multiple sclerosis disease modifying therapies in vitro. |
2024-05-26 |
2024-05-31 |
mouse |
| Rosa Cortese, Marco Battaglini, Ferran Prados, Giordano Gentile, Ludovico Luchetti, Alessia Bianchi, Lukas Haider, Anu Jacob, Jacqueline Palace, Silvia Messina, Friedemann Paul, Romain Marignier, Françoise Durand-Dubief, Carolina de Medeiros Rimkus, Samira Luisa Apostolos Pereira, Douglas Kazutoshi Sato, Massimo Filippi, Maria Assunta Rocca, Laura Cacciaguerra, Àlex Rovira, Jaume Sastre-Garriga, Georgina Arrambide, Yaou Liu, Yunyun Duan, Claudio Gasperini, Carla Tortorella, Serena Ruggieri, Maria Pia Amato, Monica Ulivelli, Sergiu Groppa, Matthias Grothe, Sara Llufriu, Maria Sepulveda, Carsten Lukas, Barbara Bellenberg, Ruth Schneider, Piotr Sowa, Elisabeth G Celius, Anne-Katrin Pröbstel, Cristina Granziera, Özgür Yaldizli, Jannis Müller, Bruno Stankoff, Benedetta Bodini, Frederik Barkhof, Olga Ciccarelli, Nicola De Stefan. Grey Matter Atrophy and its Relationship with White Matter Lesions in Patients with Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease, Aquaporin-4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder, and Multiple Sclerosis. Annals of neurology. 2024-05-23. PMID:38780377. |
grey matter atrophy and its relationship with white matter lesions in patients with myelin oligodendrocyte glycoprotein antibody-associated disease, aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder, and multiple sclerosis. |
2024-05-23 |
2024-05-27 |
Not clear |
| Rosa Cortese, Marco Battaglini, Ferran Prados, Giordano Gentile, Ludovico Luchetti, Alessia Bianchi, Lukas Haider, Anu Jacob, Jacqueline Palace, Silvia Messina, Friedemann Paul, Romain Marignier, Françoise Durand-Dubief, Carolina de Medeiros Rimkus, Samira Luisa Apostolos Pereira, Douglas Kazutoshi Sato, Massimo Filippi, Maria Assunta Rocca, Laura Cacciaguerra, Àlex Rovira, Jaume Sastre-Garriga, Georgina Arrambide, Yaou Liu, Yunyun Duan, Claudio Gasperini, Carla Tortorella, Serena Ruggieri, Maria Pia Amato, Monica Ulivelli, Sergiu Groppa, Matthias Grothe, Sara Llufriu, Maria Sepulveda, Carsten Lukas, Barbara Bellenberg, Ruth Schneider, Piotr Sowa, Elisabeth G Celius, Anne-Katrin Pröbstel, Cristina Granziera, Özgür Yaldizli, Jannis Müller, Bruno Stankoff, Benedetta Bodini, Frederik Barkhof, Olga Ciccarelli, Nicola De Stefan. Grey Matter Atrophy and its Relationship with White Matter Lesions in Patients with Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease, Aquaporin-4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder, and Multiple Sclerosis. Annals of neurology. 2024-05-23. PMID:38780377. |
to evaluate: (1) the distribution of gray matter (gm) atrophy in myelin oligodendrocyte glycoprotein antibody-associated disease (mogad), aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder (aqp4+nmosd), and relapsing-remitting multiple sclerosis (rrms); and (2) the relationship between gm volumes and white matter lesions in various brain regions within each disease. |
2024-05-23 |
2024-05-27 |
Not clear |